Medserv has been named Malta Stock Exchange Company of the Year for 2016. The award was announced during the annual Stock Exchange dinner where Joseph Portelli, chairman of the Malta Stock Exchange, presented the award to the company’s chairman, Anthony Diacono.

The Company of the Year Award was presented to Medserv in acknowledgment of its financial results as well as a positive corporate social responsibility and corporate governance culture.

Mr Portelli said: “The Malta Stock Exchange analysed the full-year results of 23 companies listed on the MSE for the year 2015 and the first half of 2016. The board selected for Company of the Year a company whose growth metric for 2015 was, to say the least, very impressive. Revenue growth of 35 per cent, earnings per share growth of 94 per cent, return on equity of 41 per cent – and all of this in a challenging market environment. Medserv is also the only listed company to engage an outside research firm at a considerable expense to carry out independent analysis of its future prospects. This is something all shareholders should appreciate and we would like to see more companies do”.

Mr Diacono said Medserv always advocated the importance of transparency and appreciates the value of providing shareholders and the market in general with information and the visibility they require.

“The engagement of a reputed, independent analyst such as Edison is another step to reinforce our commitment to the market,” said Mr Diacono. “We couldn’t be prouder that the Malta Stock Exchange has bestowed this award on us, especially in such times where the environment in the oil and gas market is challenging. Our strategy to continue to reinvest and diversify even in challenging circumstances has seen the company grow from strength to strength and this award supports our philosophy.”

Sign up to our free newsletters

Get the best updates straight to your inbox:
Please select at least one mailing list.

You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.